Elanco Animal Health (ELAN) to Release Earnings on Tuesday

Elanco Animal Health (NYSE:ELAN) is anticipated to announce its earnings results before the market opens on Tuesday, February 25th. Analysts expect the company to announce earnings of $0.16 per share and revenue of $1.01 billion for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link.

Elanco Animal Health Stock Down 1.0 %

ELAN stock opened at $11.02 on Monday. Elanco Animal Health has a one year low of $10.77 and a one year high of $18.80. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.31 and a current ratio of 2.55. The firm’s fifty day moving average is $11.80 and its 200 day moving average is $13.10. The firm has a market cap of $5.45 billion, a PE ratio of 27.54, a P/E/G ratio of 2.50 and a beta of 1.42.

Analysts Set New Price Targets

ELAN has been the topic of a number of analyst reports. Stifel Nicolaus dropped their target price on Elanco Animal Health from $18.00 to $16.00 and set a “buy” rating on the stock in a research report on Friday. Barclays raised their price objective on Elanco Animal Health from $19.00 to $20.00 and gave the company an “overweight” rating in a report on Friday, November 8th. Morgan Stanley reduced their target price on Elanco Animal Health from $15.00 to $14.00 and set an “equal weight” rating for the company in a research note on Wednesday, January 29th. UBS Group started coverage on Elanco Animal Health in a research report on Monday, December 9th. They set a “buy” rating and a $18.00 target price on the stock. Finally, Leerink Partners began coverage on shares of Elanco Animal Health in a report on Monday, December 2nd. They issued a “market perform” rating and a $14.00 price target for the company. One research analyst has rated the stock with a sell rating, four have given a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $16.00.

About Elanco Animal Health

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands.